Researchers found an association between increased activity in a reward region of the brain—primarily stimulated by hopeful thinking—and heightened levels of protective antibodies after receiving a va ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

Sweeping changes to U.S. vaccine policy under Health Secretary Robert F. Kennedy Jr. are creating uncertainty across the pharmaceutical sector, dampening investor confidence and raising concerns among ...

What Happened? Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 19.7% in the afternoon session after the ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Novavax (NASDAQ:NVAX) got a lift early Tuesday after the vaccine maker landed a licensing deal with Pfizer that puts its Matrix-M adjuvant to work in Pfizer's pipeline. Shares of Novavax were up about ...

Novavax Inc. (NASDAQ:NVAX) shares are up 3.3% to trade at $8.27 at last glance, after the vaccine company singed a licensing ...

Health Secretary RFK Jr. removed four members of the Advisory Commission on Childhood Vaccines, which advises on Vaccine ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up ...

Texas Biomedical Research Institute, one of the world's leading independent biomedical research institutions dedicated to eradicating infection and advancing health, is celebrating 85 years of bold ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

One of the primary reasons influenza is spreading so rapidly in New Jersey and beyond is a mutated variant that was discovered after this season's flu vaccine had already been formulated. The new ...